VNDA Vanda Pharmaceuticals Inc.

Pharmaceutical Preparations · Nasdaq · SEC EDGAR official

Market Value*

$268.70M

Revenue (FY)

$216.10M 2025-12-31

Net Income (FY)

$-220.47M

company in Washington D.C., United States.

Financial History annual

Interactive chart · SEC EDGAR annual filings (10-K / 20-F) · enable JavaScript if blank

*Market value = public float disclosed in latest 10-K filing · CIK 1347178 · SEC filings · revenue ranking · home